Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. tumor specificity
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
  • Custom manufacturer
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • Monitoring and Testing
  • Agriculture
  • Health and Safety
  • University / Academia / Research
  • Manufacturing, Other
Employees

  • 101-1000
  • 11-100

Tumor Specificity Suppliers & Manufacturers

43 companies found

Cancer Targeted Technology

Cancer Targeted Technology

based inWoodinville, WASHINGTON (USA)
Cancer Targeted Technology is designing and patenting small molecular weight enzyme inhibitors with unique and exceptional imaging and drug delivery properties. Cancer Targeted Technology (CTT) develops innovative targeted agents for cancer that ...
Model CTT1403 - PSMA-targeted 177Lu-Labeled Agent for Prostate Cancer

Model CTT1403 - PSMA-targeted 177Lu-Labeled Agent for Prostate Cancer

CTT’s lead therapeutic product, CTT1403, is a PSMA-targeted 177Lu-labeled agent for prostate cancer that can has superior binding characteristics, long circulation half-life, enhanced tumor uptake and unparalleled ...
CONTACT SUPPLIER

MedChemExpress LLC (MCE)

MedChemExpress LLC (MCE)

based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
MedChemExpress - Model 2’3’-c-di-AM(PS)2 (Rp,Rp) ammonium salt - 1638750-96-5

MedChemExpress - Model 2’3’-c-di-AM(PS)2 (Rp,Rp) ammonium salt - 1638750-96-5

2’3’-c-di-AM(PS)2 (Rp,Rp) ammonium salt (ADU-S100 ammonium salt), an activator of stimulator of interferon genes (STING), leads to potent and systemic tumor regression and ...
CONTACT SUPPLIER

Myeloid Therapeutics

Myeloid Therapeutics

based inCambridge, MASSACHUSETTS (USA)
Myeloid Therapeutics is a leader in the development of mRNA-based immunotherapies, focusing on harnessing and enhancing the natural capabilities of myeloid cells to combat cancer. The company's cutting-edge in vivo engineering platform is designed ...
mRNA Cell Therapy Technology

mRNA Cell Therapy Technology

Myeloid is focused on advancing its ATAK CAR monocytes, which are myeloid cells with innate immune receptor-inspired CARs to recognize and kill cancer. Additionally, Myeloid has streamlined manufacturing for its ATAK cell therapy candidates through ...
CONTACT SUPPLIER

ViciniVax BV

ViciniVax BV

based inGroningen, NETHERLANDS
ViciniVax is a Dutch clinical stage biopharmaceutical company. It is a spin-off from the University Medical Center Groningen, the Netherlands, developing therapeutic cancer vaccines. Our first product candidate Vvax001, a therapeutic cancer vaccine ...
ViciniVax - Model Vvax001 - Therapeutic Cancer Vaccine

ViciniVax - Model Vvax001 - Therapeutic Cancer Vaccine

Our first product candidate Vvax001, a therapeutic cancer vaccine against (pre)malignant cervical lesions, is currently in clinical development. We outsource process development and GMP manufacturing to experienced CMO’s, leading to a first ...
CONTACT SUPPLIER

Zymeworks Inc

Zymeworks Inc

based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
Azymetric - Tailored Multifunctional Therapeutics

Azymetric - Tailored Multifunctional Therapeutics

Azymetric™ is the best-in-class platform for therapeutic antibodies that can simultaneously bind to multiple distinct locations on a target or to multiple targets, resulting in unique mechanisms of action not accessible through typical ...
CONTACT SUPPLIER

Hookipa Pharma Inc.

Hookipa Pharma Inc.

based inVienna, AUSTRIA
Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our non-replicating and ...
Immune System of Arenavirus Platform

Immune System of Arenavirus Platform

The immune system is the body’s natural defense mechanism against pathogens. Our proprietary technology is capable of targeting and treating disease with a tailored immune response. Our science is based on a novel and highly differentiated ...
CONTACT SUPPLIER

Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc.

based inHouston, TEXAS (USA)
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01. GP2 is derived ...
Greenwich - Model GP2 - Nine Amino Acid Transmembrane Peptide of the HER2/Neu Protein

Greenwich - Model GP2 - Nine Amino Acid Transmembrane Peptide of the HER2/Neu Protein

Following breast cancer surgery, a HER2/neu 3+ patient receives trastuzumab (Genentech/Roche’s Herceptin, a monoclonal antibody treatment that targets the HER2/neu protein) in the first year and then hopes that their breast cancer will not ...
CONTACT SUPPLIER

Treos Bio Limited

Treos Bio Limited

based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Treos - Personal Antigen Selection Calculator Technologies (PASCal)

Treos - Personal Antigen Selection Calculator Technologies (PASCal)

At TREOS we use knowledgebase and algorithm embedded in PASCal (Personal Antigen Selection Calculator) tool to develop personal cancer immunotherapies. PASCal supports the development of immunotherapies for single individuals and a population of ...
CONTACT SUPPLIER

NEC OncoImmunity AS 

NEC OncoImmunity AS 

based inOslo, NORWAY
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer ...
NEC - Immune Profiler Software

NEC - Immune Profiler Software

The NEC Immune Profiler Provides an Holistic Approach to Antigen Presentation Prediction. NEC OncoImmunity AS has developed an AI engine for its clinical projects, known as the NEC Immune Profiler, that predicts from next generation sequencing data ...
CONTACT SUPPLIER

Sumitomo Pharma Oncology, Inc.

Sumitomo Pharma Oncology, Inc.

based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
CONTACT SUPPLIER

Elicio Therapeutics

Elicio Therapeutics

based inBoston, MASSACHUSETTS (USA)
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...
Elicio - Model ELI-007 - Multivalent Lymph Node–Targeted AMP Peptide Vaccine

Elicio - Model ELI-007 - Multivalent Lymph Node–Targeted AMP Peptide Vaccine

BRAF mutations are present in multiple types of cancer, including 40% in melanoma, 9% in colorectal cancer (CRC), and 2% in lung cancer. High levels of BRAF protein expression in these tumors suggest susceptibility to T cells ...
CONTACT SUPPLIER

Invivoscribe, Inc.

Invivoscribe, Inc.

based inSan Diego, CALIFORNIA (USA)
Invivoscribe is a global leader in molecular diagnostics, providing a comprehensive range of standardized, CE-marked in vitro diagnostic products and companion diagnostics for hematology-oncology. The company's offerings include research use only ...
CONTACT SUPPLIER

Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.

based inCambridge, MASSACHUSETTS (USA)
Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with ...
CONTACT SUPPLIER

Vitanova Biomedical, Inc. (VNB)

Vitanova Biomedical, Inc. (VNB)

based inKerrville, TEXAS (USA)
Vitanova Biomedical, Inc. (VNB) is a San Antonio, TX-based early stage biotechnology company developing patented (pending) technology licensed from the University of Texas at San Antonio. The company’s cancer treatment, Light-Activated Intracellular ...
Vitanova - Light-Activated Intracellular Acidosis (LAIA)

Vitanova - Light-Activated Intracellular Acidosis (LAIA)

Vitanova Biomedical’s Cancer Therapy Technology Platform is Called Light-Activated Intracellular Acidosis (LAIA). Vitanova Biomedical (VNB) has developed a proprietary energy-based technique to elicit cancer-specific intracellular acidosis. ...
CONTACT SUPPLIER

NanoString

NanoString

based inSeattle, WASHINGTON (USA)
As the pioneer in the field of spatial biology, NanoString enables scientists across the globe to envision molecular interactions in three dimensions with three different systems, the nCounter Analysis System, the GeoMx Digital Spatial Profiler ...
CONTACT SUPPLIER

SOPHiA Genetics

SOPHiA Genetics

based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries.  Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
MSK-ACCESS Powered with SOPHiA DDM - In-House Liquid Biopsy

MSK-ACCESS Powered with SOPHiA DDM - In-House Liquid Biopsy

Rise above the noise to see what truly matters. Elevate your precision oncology program. Push the boundaries of your in-house liquid biopsy capabilities with MSK-ACCESS® powered with SOPHiA DDM™, a decentralized version of the rigorously ...
CONTACT SUPPLIER

CDR-Life

CDR-Life

based inSchlieren, SWITZERLAND
We want to empower people to deal with their malignant cells through their own immune system just like we deal with viral infections. Today’s cancer immunotherapies are powerful but, to the detriment of their effect, not very tumor-selective. ...
Antibody Therapies

Antibody Therapies

CDR-Life’s T cell engaging antibodies are potentially transformative in the field of cancer immunotherapies» Prof. Markus G. Manz, MD, Head of Medical Oncology and Hematology at University Hospital and University of Zurich, Switzerland. ...
CONTACT SUPPLIER

Aphios Corporation

Aphios Corporation

based inWoburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Aphios - Model APH-0912 - Combination of A Taxotere® Prodrug And Monoclonal Antibody

Aphios - Model APH-0912 - Combination of A Taxotere® Prodrug And Monoclonal Antibody

The prodrug is a combination of a docetaxel molecule, the potent anticancer drug, and a sugar molecule to enhance solubility covalently linked to a tumor-specific antibody. This molecular combination is not ...
CONTACT SUPPLIER

Scancell

Scancell

based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
GlyMab - Model Anti-glycan mAb - Antibodies for Cancer

GlyMab - Model Anti-glycan mAb - Antibodies for Cancer

Glycosylation is a post-translational modification that occurs inside the cell and results in the addition of sugar motifs, “glycans”, to proteins and lipids that are, in most cases, destined for the cell surface. These glycan structures ...
CONTACT SUPPLIER

NeraCare GmbH

NeraCare GmbH

based inFrankfurt, GERMANY
NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer. The tests provide actionable, tumor-specific information for each individual patient. The information is used to make improved treatment decisions, i.e. ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT